Krka reports record sales in H1, appoints two supervisors
Otočec, 6 July - Krka, the Novo mesto-based pharmaceutical group, reported it generated a record EUR 655m in sales in the first half of 2017 at the group level, up 8.5% year-on-year, while net profit was up by 31% to EUR 91.7m. Its shareholders meanwhile appointed two new supervisors and confirmed a dividend payout of EUR 2.75 gross per share.
The rest of this news item is available to subscribers.
The news item consists of 2.358 characters (without spaces) or 481 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.